The Infiltration of Terrorist Organizations Into the Pharmaceutical Industry: Hezbollah as a Case Study

Boaz Ganor and Miri Halperin Wernli

Studies in Conflict and Terrorism, 2013, vol. 36, issue 9, 699-712

Abstract: Criminal syndicates and terrorist organizations are inherently different, one motivated by profit and the other by political goals. Yet their difference enables them to cooperate for their mutual benefit. Nowhere has this been more evident than in the drug trade; from harvesting and trafficking in illegal substances, it has been an easy transition to counterfeiting and disseminating medications. Hezbollah, in particular, has become involved in the production, smuggling and distribution of counterfeit medications in North America, Africa and the Middle East as a means of raising immense sums of money to finance its terrorist activities. Hezbollah's infiltration into the pharmaceuticals industry illustrates the danger posed by the marriage of terrorism and crime, which arises both from enhanced resources for terrorism, and from the corruption of a legitimate and necessary industry. Understanding the nature and extent of this danger is the first step in preparing to meet it.

Date: 2013
References: Add references at CitEc
Citations:

Downloads: (external link)
http://hdl.handle.net/10.1080/1057610X.2013.813244 (text/html)
Access to full text is restricted to subscribers.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:taf:uterxx:v:36:y:2013:i:9:p:699-712

Ordering information: This journal article can be ordered from
http://www.tandfonline.com/pricing/journal/uter20

DOI: 10.1080/1057610X.2013.813244

Access Statistics for this article

Studies in Conflict and Terrorism is currently edited by Bruce Hoffman

More articles in Studies in Conflict and Terrorism from Taylor & Francis Journals
Bibliographic data for series maintained by Chris Longhurst ().